Dopesick: Dealers, Doctors, and the Drug Company That Addicted America
Beth Macy
Chronicles America's more than twenty-year struggle with opioid addiction, from the introduction of OxyContin in 1996, through the spread of addiction in distressed communities in Central Appalachia, to the current national crisis.
Award History
1 wins · 4 total
| Award | Year | Result | Category / Notes |
|---|---|---|---|
| Los Angeles Times Book Prize for Science and TechnologyMajor | 2018 | Winner | Secondary source |
| Andrew Carnegie Medal for Excellence in NonfictionMajor | 2019 | Finalist | Official source |
| Kirkus Prize for NonfictionMajor | 2018 | Finalist | Official source |
| Helen Bernstein Book Award for Excellence in Journalism | 2019 | Finalist | Secondary source |
Experimental book profileGenerated by GPT-5.4 nano · may contain inaccuracies
This is an unverified interpretation of the catalog description, offered as an opt-in discovery experiment—not as bibliographic fact.
01 Central figures
None extracted with sufficient confidence.
02 Central places
None extracted with sufficient confidence.
These suggestions did not meet the normal display threshold and are more likely to be wrong.
- Central Appalachia65%
- America42%
03 Suggested argument
The book depicts America’s more than twenty-year opioid addiction struggle as beginning with OxyContin’s 1996 introduction and spreading into distressed communities, culminating in a national crisis.
Model confidence 62%
04 Reading orientation
32 / 100 academicSerious trade
An estimate of intended readership and scholarly apparatus—not quality or importance.
Confidence percentages are the model's own estimates. Profile confidence: 66%.